Condition: Systemic Lupus Erythematosus · Sponsor: Heinrich-Heine University, Duesseldorf
Multicenter, national, two-armed cluster-randomized controlled trial to evaluate the effect of a treat-to-target (T2T) strategy in in systemic lupus erythematosus (SLE). 14 centers will be randomized 1:1 to T2T or standard of care. Per arm 303 patients with SLE who are not in remission will be included and receive either tight control with 6-weekly visits with the aim to reach remission or SoC with control visits and treatment adjustment according to the physicians discretion. Study duration is 120 weeks using damage accrual and Health related Quality of Life as major outcomes.
This description comes directly from the study's public registry record.
Matthias Schneider, MD · 0211 81 17817 · lupus-best@rheumanet.org
Johanna Mucke, MD · 02118117817 · lupus-best@rheumanet.org
Always discuss trial participation with your own doctor first.
| University Clinic Freiburg | Freiburg im Breisgau, Baden-Wurttemberg, Germany | Recruiting |
| University Clinic Heidelberg | Heidelberg, Baden-Wurttemberg, Germany | Recruiting |
| University Clinic Erlangen | Erlangen, Bavaria, Germany | Not Yet Recruiting |
| LMU Munich | Munich, Bavaria, Germany | Recruiting |
| University Clinic Frankfurt | Frankfurt am Main, Hesse, Germany | Recruiting |
| Medical University Hannover | Hanover, Lower Saxony, Germany | Recruiting |
| University Clinic Düsseldorf | Düsseldorf, North Rhine-Westphalia, Germany | Recruiting |
| Kliniken Essen Mitte, Essen | Essen, North Rhine-Westphalia, Germany | Recruiting |
| Rheumazentrum Ruhrgebiet Herne, Ruhr University Bochum | Herne, North Rhine-Westphalia, Germany | Recruiting |
| University Clinic Münster | Münster, North Rhine-Westphalia, Germany | Recruiting |
| University Clinic Mainz | Mainz, Rhineland-Palatinate, Germany | Recruiting |
| University Medical Center TU Dresden | Dresden, Saxony, Germany | Recruiting |
+ 2 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05714930